Xanomeline/Trospium Chloride
The question
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the effectiveness of Cobenfy; and whether he is taking steps to licence this medication in the UK.
Answered by Karin Smyth
The Medicines and Healthcare products Regulatory Agency has not received an application for the Market Authorisation of Cobenfy by the Bristol-Myers Squibb Company.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →